Company intelligence / Profile preview

X-ZELL

Ownership: Private
Employees: ~19
Development stage: Preclinical

Overview

X-ZELL has demonstrated that its Cryoimmunostaining™ technology can outperform traditional immunostaining methods for detecting atypical/cancerous cells in minimally invasive body fluids. The technology has been adopted by leading pathology centers such as MVZ Frankfurt and validated through landmark studies and routine clinical use since at least mid–2024.[1][2] A major trial on early blood-based prostate cancer detection began in Singapore in late 2021.[1]

The company’s approach enables same-day diagnoses with higher efficiency and data retention compared to conventional methods.[2]

Therapeutic areas: Oncology
Modalities: DeviceDiagnostic platform (multi-channel immunostaining with digital single-cell imaging)Immunofluorescence staining system (Cryoimmunostaining™)
Industry: Pathology

Partnerships

MVZ Frankfurt – German cytopathology center adopting Cryoimmunostaining™ as routine method [1]DxD Hub Singapore – R&D collaboration to fast-track commercialization [1]

Beyond the preview

Go deeper on X-ZELL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on X-ZELL.

Explore the full profile